In the early nineties, Dr. Cynthia Brinson, Dr. David Wright, and Dr. Gary Werntz worked for the family practice residency program of The Central Texas Medical Foundation. The foundation had an HIV study group that enabled patients to get access to the latest drugs via clinical trials. Dr. Brinson and Dr. Wright were investigators for the HIV study group, and Dr. Werntz referred patients.
Central Texas Clinical Research was founded in 1999 as a dedicated clinical research facility to provide new treatments for HIV patients. We have conducted over 100 trials and worked with most major pharmaceutical companies and contact research organizations (CROs). In addition to being the premier HIV study site in Central Texas, we also have experience with studies in a wide range of therapeutic areas including hepatitis C, hypertension, pain, weight loss, diabetes, cardiac, vaccine, migraine, lipid, anemia, neuropathy, and HIV/HEP C co-infection.
We are located in the Park St. David’s Professional Building next door to St. David’s and just one block from the University of Texas. We conduct phase I-IV clinical trials with subjects age 18 and older. We recruit from all ethnic groups, and the gender of our patients is split about 50/50 between males and females. We recruit patients from our physicians’ private practices, our patient database, referrals from outside physicians, and advertising. We are often the highest enroller for a given study.
We plan to conduct clinical trials for many years to come, build relationships with sponsors and study-subjects, add to our patient database, and provide high quality data on new therapeutic options. We believe that by doing so we can benefit people throughout the world.